AIDS Community Research Initiative of America Img

AIDS Community Research Initiative of America

Mission & History

ACRIA was founded as the Community Research Initiative on AIDS (CRIA) in December 1991 by a group of physicians, activists, and people living with HIV who were frustrated by the slow pace of government and academic AIDS research. Under the pioneering leadership of prominent AIDS physicians and researchers like Drs. Joseph Sonnabend and Mathilde Krim, and following the lead of trailblazers like Michael Callen of the PWA Coalition, this truly dynamic group brought an activist approach to the study of new treatments for HIV and AIDS. Since that time we have contributed to the development of more than a dozen medications that have received FDA approval, helping countless thousands of HIV-positive people live longer, healthier lives.

ACRIA added a treatment education component to its efforts in 1997, offering group workshops and individual counseling on a variety of AIDS- and HIV-related topics, arming people living with the virus with the information and skills they need to participate actively and knowledgeably in their own healthcare. Today, our internationally acclaimed HIV Health Literacy Program (HHLP) also offers staff training to a whole range of AIDS and other community-based organizations throughout New York City and State, and in communities large and small all across the country. Our technical assistance and capacity building equip these groups to integrate HIV healthcare and treatment education information into the services they provide their own HIV-positive and at-risk clients.

Our HIV health literacy activities have likewise grown to include the publication of unique booklets, each addressing a different key topic in HIV healthcare. Our library includes Treatment Issues for Women, Managing Drug Side Effects, Viral Hepatitis & HIV, Understanding Your Lab Results, and Older Adults & HIV, among others. Additionally, our treatment and health literacy quarterly, ACHIEVE, is distributed to tens of thousands of people living with HIV and their caregivers each year, helping them to make smart, informed decisions and stay healthy.

How to Reach AIDS Community Research Initiative of America

AIDS Community Research Initiative of America
230 W. 38th St., 17th Floor
New York, NY 10018

Phone: 212.924.3934
Fax: 212.924.3936

Latest by AIDS Community Research Initiative of America

Activists Caution HIV-Positive Patients and Their Physicians About Monotherapy in Upcoming Access Program

New York -- AIDS activists and physician advocates welcome the news that ViiV Healthcare will be providing expanded access of dolutegravir (DTG), a new investigational integrase inhibitor for HIV patients with few remaining HIV treatment options. How...


Health Care Provider Survey: Looking for HIV+ Patients With No Remaining HIV Treatment Options

Dear Colleague: Over the past year, ACRIA has been working with key pharmaceutical companies, colleagues in San Francisco (Drs. Lalezari and Deeks), and a community HIV activist (Nelson Vergel) to develop a unique, multi-drug expanded access program...

Older Adults (Ages 50+)

Older Adults and HIV: A Special Report and Action Plan

Table of Contents Aging and HIV: An Overview Older Adults and HIV: Recent Findings Priority Policy Recommendations Conclusion Footnotes References Aging and HIV: An Overview By 2015 a majority of people with HIV in the United States will...

Hepatitis C

HIV and Hepatitis C: Learn the Facts, Take Action

It has been five years since ACRIA last took an in-depth look at the hepatitis C virus (HCV). But it remains a serious and, unfortunately, very common comorbidity of HIV. HIV both increases the likelihood of contracting HCV and complicates its treatm...

Hepatitis C

Hepatitis C: A Closer Look

Many people living with HIV must deal with not only one virus, but also with a co-traveler: hepatitis C virus (HCV), which infects liver cells. For some, the liver is only slightly damaged since it is able to make new cells and bounce back. But for o...

Hepatitis C

Hepatitis C Treatment Today

The decision to start treatment for hepatitis C must be shared by doctor and patient, and everyone with a chronic hep C infection should be evaluated for treatment. But since the treatment can cause difficult side effects, and is less effective in pe...

Hepatitis C

Personal Perspective: The Whys and Hows of Me and Treatment

My name is Donald and I'm an addict. I can say that today only because I'm in recovery after years of use and abuse. I managed to experience and experiment with a lot of different drugs, starting with alcohol and marijuana, on to LSD, PCP, uppers an...

Hepatitis C

Personal Perspective: This Too Shall Pass

Allow me to introduce myself. My name is Donna Y. Kennedy. I am a 51-year-old African-American. I am a woman, wife, mother, grandmother, daughter, sister, aunt, godmother, cousin, friend. Oh, by the way, I am coinfected with HIV and hepatitis C. I wa...

Hepatitis C

News From the Front

This year's conferences covering HIV/AIDS and liver disease featured numerous presentations concerning hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in people with HIV. Below are highlights from several of the most interesting reports...


Peering Into the Pipeline: New Drug Candidates

As I further my medical training, I find that the management of HIV remains intricate, requiring both an increasing understanding of the disease and a growing tool set. So many resources come into play when deciding on a treatment regimen, including ...